Related Experiment Video
Updated: Feb 20, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Interplay between TGF-β signaling and receptor tyrosine kinases in tumor development
1State Key Laboratory of Membrane Biology, Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, 100084, China.
Abstract:
Transforming growth factor-β (TGF-β) signaling regulates cell proliferation, differentiation, migration and death, and plays a critical role in embryogenesis and tissue homeostasis. Its deregulation results in various diseases including tumor formation. Receptor tyrosine kinases (RTKs), such as epidermal growth factor receptor (EGFR), fibroblast growth factor receptor (FGFR), vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR), also play key roles in the development and progression of many types of tumors. It has been realized that TGF-β signaling and RTK pathways interact with each other and their interplay is important for cancer development. They are mutually regulated and cooperatively modulate cell survival and migration, epithelial-mesenchymal transition, and tumor microenvironment to accelerate tumorigenesis and tumor metastasis. RTKs can modulate Smad-dependent transcription or cooperate with TGF-β to potentiate its oncogenic activity, while TGF-β signaling can in turn control RTK signaling by regulating their activities or expression. This review summarizes current understandings of the interplay between TGF-β signaling and RTKs and its influence on tumor development.
Insights
Transforming growth factor-β (TGF-β) signaling and receptor tyrosine kinases (RTKs) pathways interact to drive cancer development. Their crosstalk accelerates tumor growth and metastasis by modulating cell survival and migration.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Signaling
Background:
- Transforming growth factor-β (TGF-β) signaling is crucial for cell functions and tissue homeostasis.
- Deregulation of TGF-β signaling is linked to various diseases, notably tumor formation.
- Receptor tyrosine kinases (RTKs) are key players in tumor development and progression.
Purpose of the Study:
- To review the intricate interplay between TGF-β signaling and RTK pathways.
- To elucidate how this crosstalk influences cancer development and metastasis.
- To summarize current knowledge on their mutual regulation in tumorigenesis.
Main Methods:
- Literature review of studies investigating TGF-β and RTK signaling in cancer.
- Analysis of molecular mechanisms underlying the interaction between these pathways.
- Synthesis of findings on their cooperative roles in tumor progression.
Main Results:
- TGF-β signaling and RTKs are mutually regulated and interact significantly in cancer.
- Their interplay modulates cell survival, migration, and epithelial-mesenchymal transition.
- RTKs can enhance TGF-β's oncogenic activity, while TGF-β can control RTK expression and activity.
Conclusions:
- The crosstalk between TGF-β signaling and RTKs is a critical determinant of tumor development and metastasis.
- Understanding this interaction provides insights into potential therapeutic strategies for cancer.
- Further research into this interplay is essential for advancing cancer treatment.
Related Concept Videos
TGF - β Signaling Pathway
Receptor Tyrosine Kinases
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

